These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 14160447)

  • 1. A COMPARISON OF THE REACTIVITY OF POLIOVIRUS COMPLEMENT-FIXING ANTIGENS (NATIVE, HEATED AND SUCROSE DENSITY GRADIENT C AND D) WITH HUMAN SERA.
    LENNETTE EH; SCHMIDT NJ; MAGOFFIN RL; HAGENS SJ; DUKELLIS EJ
    J Immunol; 1964 Feb; 92():261-74. PubMed ID: 14160447
    [No Abstract]   [Full Text] [Related]  

  • 2. [ON THE VIABILITY AND RESISTANCE OF VACCINAL STRAINS OF POLIOVIRUSES IN THE EXTERNAL ENVIRONMENT].
    BYCHKOVSKAIA OV; BABINA NS; IVANOVA OD; KISELEVA LF
    Gig Sanit; 1964 Aug; 29():45-9. PubMed ID: 14249261
    [No Abstract]   [Full Text] [Related]  

  • 3. ANTIGENIC DIFFERENTIATION OF POLIOVIRUSES BY ABSORBED HYPERIMMUNE SERA. I. ANTIGENIC DIFFERENTIATION OF TYPE I STRAINS OF DIVERSE ORIGIN.
    EYLAN E; FOGEL A; DUKLER R; RANNON L
    J Immunol; 1965 Jul; 95():171-80. PubMed ID: 14328695
    [No Abstract]   [Full Text] [Related]  

  • 4. ANTIGENIC VARIATIONS AMONG TYPE III POLIOMYELITIS VIRUSES.
    DEIBEL R; MACDONALD D
    N Y State J Med; 1964 Aug; 64():2058-65. PubMed ID: 14180893
    [No Abstract]   [Full Text] [Related]  

  • 5. INTRATYPIC SERODIFFERENTIATION TESTS ON POLIO TYPE 1 VIRUS STRAINS ISOLATED BEFORE AND AFTER VACCINATION WITH ATTENUATED SABIN TYPE 1 POLIO VACCINE.
    HAHNEMANN F; SIBONI K; GODTFREDSEN A
    Acta Pathol Microbiol Scand; 1964; 61():437-45. PubMed ID: 14164891
    [No Abstract]   [Full Text] [Related]  

  • 6. COMPLEMENT-FIXING ANTIBODY RESPONSE AFTER ADMINISTRATION OF INACTIVATED AND ORAL POLIOVIRUS VACCINES.
    ZAVADOVA H; ZACEK K; VONKA V
    J Hyg Epidemiol Microbiol Immunol; 1963; 7():487-94. PubMed ID: 14114944
    [No Abstract]   [Full Text] [Related]  

  • 7. THE USE OF A MODIFIED WECKER TECHNIQUE FOR SERODIFFERENTIATION OF TYPE 1 POLIOVIRUSES RELATED AND UNRELATED TO SABIN'S VACCINE STRAIN. II. ANTIGENIC SEGREGATION OF ISOLATES FROM SPECIMENS COLLECTED IN FIELD STUDIES.
    NAKANO JH; GELFAND HM; COLE JT
    Am J Hyg; 1963 Sep; 78():214-26. PubMed ID: 14063724
    [No Abstract]   [Full Text] [Related]  

  • 8. [SOME REMARKS ON PREPARATION OF POLIO HYPERIMMUNE SERA].
    SCHMIDT WA
    Zentralbl Bakteriol Orig; 1963 Aug; 189():538-42. PubMed ID: 14112884
    [No Abstract]   [Full Text] [Related]  

  • 9. CONVENTIONAL TISSUE CULTURE NEUTRALIZATION TECHNIQUE EMPLOYED IN SERODIFFERENTIATION BETWEEN TYPE 1 POLIOVIRUSES.
    HAHNEMANN F; SIBONI K
    Acta Pathol Microbiol Scand; 1964; 61():75-80. PubMed ID: 14150637
    [No Abstract]   [Full Text] [Related]  

  • 10. IMMUNOLOGICAL CHARACTERIZATION OF VILYUISK HUMAN ENCEPHALOMYELITIS VIRUS.
    CASALS J
    Nature; 1963 Oct; 200():339-41. PubMed ID: 14087883
    [No Abstract]   [Full Text] [Related]  

  • 11. [STUDIES ON THE COMPLEMENT-BINDING REACTION OF POLIOMELITIS. V. USE OF 11 SEROLOGICALLY DEFINED TYPE I AND TYPE II ANTIGENS IN EXAMINATION OF PATIENT SERA].
    SCHMIDT WA; HOEPKEN W; WOHLRAB R
    Arch Gesamte Virusforsch; 1964 Mar; 14():521-36. PubMed ID: 14184627
    [No Abstract]   [Full Text] [Related]  

  • 12. PRODUCTION OF SPECIFIC NEUTRALIZING ANTIBODY WITH SOLUBLE ANTIGENS OF TYPE 5 ADENOVIRUS.
    WILCOX WC; GINSBERG HS
    Proc Soc Exp Biol Med; 1963 Oct; 114():37-42. PubMed ID: 14076907
    [No Abstract]   [Full Text] [Related]  

  • 13. Fluorescent-antibody studies with antisera against heated and unheated poliovirus type 1.
    Hatch MH
    Appl Microbiol; 1969 Jul; 18(1):98-103. PubMed ID: 4308536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A STUDY OF THE STORAGE STABILITY OF VIRAL ANTISERA.
    NAGLER FP; POLLEY JR
    Can J Microbiol; 1965 Jun; 11():503-7. PubMed ID: 14346126
    [No Abstract]   [Full Text] [Related]  

  • 15. [Studies of the antigenic components of Coxsackie and ECHO viruses and their antibodies].
    Schmidt WA
    Arch Gesamte Virusforsch; 1971; 33(1):77-87. PubMed ID: 4325978
    [No Abstract]   [Full Text] [Related]  

  • 16. STUDIES ON THE SALK AND LIVE ATTENUATED POLIOVIRUS VACCINE.
    NISHIZAWA Y; KODAMA T; MAJIMA E; ARAKI M; CHIN S
    Biken J; 1963 Jul; 6():97-110. PubMed ID: 14147708
    [No Abstract]   [Full Text] [Related]  

  • 17. ANTIGENIC ANALYSIS OF VIRULENT AND ATTENUATED TYPE I POLIOVIRUSES BY QUANTITATIVE COMPLEMENT FIXATION.
    GERBER P; BIRCH SM
    J Immunol; 1965 Jul; 95():70-4. PubMed ID: 14322581
    [No Abstract]   [Full Text] [Related]  

  • 18. [VIRUS ANTIGEN ANTISERUM FOR DIAGNOSTIC USE].
    ARAI H
    Sogo Rinsho; 1964 Jul; 13():1230-3. PubMed ID: 14178419
    [No Abstract]   [Full Text] [Related]  

  • 19. PRODUCTION AND STANDARDIZATION OF ADENOVIRUS TYPES 1 TO 18 REFERENCE ANTISERA.
    RAFAJKO RR
    Am J Hyg; 1964 May; 79():310-9. PubMed ID: 14159950
    [No Abstract]   [Full Text] [Related]  

  • 20. [STUDIES ON THE COMPLEMENT FIXATION REACTION IN ACUTE POLIOMYELITIS. 3. ON ITS CLINICAL APPLICATION WITH SPECIAL REFERENCE TO THE PATHOLOGICAL SIGNIFICANCE OF POLIOVIRUS IN VARIOUS NEUROLOGIC DISEASES].
    YAMADA M
    Nihon Shonika Gakkai Zasshi; 1964 Feb; 68():128-35. PubMed ID: 14135000
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.